Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Medpace Holdings is a full service, clinical contract research organization. It provides outsourced...
— C.T. Fitzpatrick
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Medpace Holdings, Inc.
Medpace is a global clinical contract research organization featuring a robust balance sheet and strong cash generation. While near-term growth...
Our investments in drug development companies like Charles River Labs (CRL) and Medpace Holdings (MEDP) pulled back, driven by AI disruption fears.
Medpace posted strong Q2 results that beat expectations on both top and bottom lines, leading to a full-year guidance upgrade. Furthermore, massive share...
More institutional theses from Vulcan Value Partners - All Cap
Diageo is a dominant global spirits producer with iconic brands, strong pricing power, and high returns on invested capital. Short-term market weakness...
Ibstock benefits from structural UK housing shortages and domestic production deficits that confer significant long-term pricing power. High interest rates...
TransDigm continues to leverage its proprietary component portfolio, which generates 90% of net sales, to drive exceptional profitability. Rebounding commercial air...